Current use and development of vaccines for Japanese encephalitis

Bibliography

• Solomon T. Flavivirus encephalitis. N Engl J Med 2004;351(4):370-8
   PubMed Web of Science ®Google Scholar
• Solomon T, Dung NM, Kneen R, et al. Japanese encephalitis. J Neurol Neurosurg Psychiatry 2000;68(4):405-15
   PubMed Web of Science ®Google Scholar
• Halstead SB, Tsai TF. Japanese encephalitis vaccines. In: Vaccines. Plotkin SA, Orenstein WA, editors. Saunders, Philadelphia, PA, USA; 2004. pp. 919-58
   Google Scholar
• WHO. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: World Health Organization, 2003
   Google Scholar
• Ketel WB, Ognibene AJ. Japanese B encephalitis in Vietnam. Am J Med Sci 1971;261(5):271-9
   PubMed Web of Science ®Google Scholar
• Kumar R, Mathur A, Singh KB, et al. Clinical sequelae of Japanese encephalitis in children. Indian J Med Res 1993;97:9-13
   PubMed Web of Science ®Google Scholar
• Huy BV, Tu HC, Luan TV, Lindqvist R. Early mental and neurological sequelae after Japanese B encephalitis. Southeast Asian J Trop Med Public Health 1994;25(3):549-53
   PubMedGoogle Scholar
• IASR. Japanese encephalitis, Japan, 1999 – 2002. Infectious Agents Surveillance Report 2003;24:149-50
   Google Scholar
• Sohn YM, Park MS, Rho HO, et al. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine 1999;17(18):2259-64
   PubMed Web of Science ®Google Scholar
• Sohn YM. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg Infect Dis 2000;6(1):17-24
   PubMed Web of Science ®Google Scholar
• Tseng HF, Tan HF, Chang CK, Huang WL, Ho WC. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships. Am J Infect Control 2003;31(7):435-40
   PubMed Web of Science ®Google Scholar
• Liu W, Clemens JD, Yang JY, Xu ZY. Immunization against Japanese encephalitis in China: a policy analysis. Vaccine 2006;24(24):5178-82
   PubMed Web of Science ®Google Scholar
• Endy TP, Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 2002;267:11-48
   PubMed Web of Science ®Google Scholar
• Padma TV. Encephalitis outbreak finds Indian officials unprepared. Nat Med 2005;11(10):1016
   PubMedGoogle Scholar
• Parida M, Dash P, Tripathi N. Japanese Encephalitis Outbreak, India, 2005. Emerg Infect Dis 2006;12(9):1427-30
   PubMed Web of Science ®Google Scholar
• Immunization and Vaccine Development – Japanese Encephalitis. Available at: URL: www.searo.who.int/en/section1226/section2073.asp [last accessed December 2007]
   Google Scholar
• Uchil P, Satchidanandam V. Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg 2001;65(3):242-51
   PubMed Web of Science ®Google Scholar
• Solomon T, Ni H, Beasley D, et al. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 2003;77(5):3091-8
   PubMed Web of Science ®Google Scholar
• Williams D, Wang L, Daniels P, MacKenzie J. Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain. J Gen Virol 2000;81(Pt 10):2471-80
   PubMed Web of Science ®Google Scholar
• Ma S, Yoshida Y, Makino Y, et al. Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am J Trop Med Hyg 2003;69(2):151-4
   PubMed Web of Science ®Google Scholar
• Yamanaka T, Tsujimura K, Kondo T, et al. Isolation and genetic analysis of Japanese encephalitis virus from a diseased horse in Japan. J Vet Med Sci 2006;68(3):293-5
   PubMed Web of Science ®Google Scholar
• Nga P, Del Carmen Parquet M, Cuong V, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol 2004;85(Pt 6):1625-31
   PubMed Web of Science ®Google Scholar
• Wang H, Takasaki T, Fu S, et al. Molecular epidemiological analysis of Japanese encephalitis virus in China. J Gen Virol 2007;88(Pt 3):885-94
   PubMed Web of Science ®Google Scholar
• Pyke A, Williams D, Nisbet D, et al. The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg 2001;65(6):747-53
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Yoshida M, Fujita S, Kobayashi Y. Comparison of structural proteins among antigenically different Japanese encephalitis virus strains. Vaccine 1994;12(9):841-4
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Yoshida M, Kobayashi Y, Fujita S. Antigenic analysis of Japanese encephalitis viruses in Asia by using monoclonal antibodies. Vaccine 1995;13(17):1713-21
   PubMed Web of Science ®Google Scholar
• Tsarev S, Sanders M, Vaughn D, Innis B. Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine 2000;18(Suppl 2):36-43
   PubMed Web of Science ®Google Scholar
• Beasley D, Li L, Suderman M, et al. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine 2004;22(27-28):3722-6
   PubMed Web of Science ®Google Scholar
• Kurane I, Takasaki T. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains. Vaccine 2000;18(Suppl 2):33-5
   PubMed Web of Science ®Google Scholar
• Monath TP, Guirakhoo F, Nichols R, et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 2003;188(8):1213-30
   PubMed Web of Science ®Google Scholar
• Chen WR, Tesh RB, Rico-Hesse R. Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 1990;71(Pt 12):2915-22
   PubMed Web of Science ®Google Scholar
• Chen W, Rico-Hesse R, Tesh R. A new genotype of Japanese encephalitis virus from Indonesia. Am J Trop Med Hyg 1992;47(1):61-9
   PubMed Web of Science ®Google Scholar
• Gould EA. Evolution of the Japanese encephalitis serocomplex viruses. Curr Top Microbiol Immunol 2002;267:391-404
   PubMed Web of Science ®Google Scholar
• Higgs S, Gould E. Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses. Arch Virol 1991;119(1-2):119-33
   PubMed Web of Science ®Google Scholar
• Ni H, Barrett A. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol 1996;77(Pt 7):1449-55
   PubMed Web of Science ®Google Scholar
• Chiou SS, Tsai KH, Huang CG, Liao YK, Chen WJ. High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus. Vaccine 2007;25(8):1437-43
   PubMed Web of Science ®Google Scholar
• WHO. Japanese encephalitis vaccines. Wkly Epidemiol Rec 2006;81(34/35):331-40
   PubMedGoogle Scholar
• Ferguson M, Kurane I, Wimalaratne O, Shin J, Wood D. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1 – 2 June 2006. Vaccine 2007;25(29):5233-43
   PubMed Web of Science ®Google Scholar
• WHO. WHO Expert Committee on Biological Standardization. Thirty-eighth report. World Health Organ Tech Rep Ser 1988;771:1-221
   PubMedGoogle Scholar
• WHO. WHO Expert Committee on Biological Standardization. World Health Organ Tech Rep Ser 2002;910:1-104
   PubMed Web of Science ®Google Scholar
• Hanna J, Ritchie S, Phillips D, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996;165(5):256-60
   PubMed Web of Science ®Google Scholar
• Hanna J, Smith G, McCulloch B, et al. An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait. Aust N Z J Public Health 2005;29(1):44-7
   PubMed Web of Science ®Google Scholar
• Abe M, Okada K, Hayashida K, et al. Duration of neutralizing antibody titer after Japanese encephalitis vaccination. Microbiol Immunol 2007;51(6):609-16
   PubMed Web of Science ®Google Scholar
• WHO. Global Advisory Committee on Vaccine Safety, 9 – 10 June 2005. Wkly Epidemiol Rec 2005;80(28):242-7
   PubMedGoogle Scholar
• Nidaira M, Taira K, Onodera I, et al. Detection of Japanese encephalitis virus antibody in a pig on Yonaguni Island, where all pigs were slaughtered in 1997. Jpn J Infect Dis 2007;60(1):70-1
   PubMed Web of Science ®Google Scholar
• Ayukawa R, Fujimoto H, Ayabe M, et al. An unexpected outbreak of Japanese encephalitis in the Chugoku district of Japan, 2002. Jpn J Infect Dis 2004;57(2):63-6
   PubMed Web of Science ®Google Scholar
• Japanese encephalitis vaccines. Wkly Epidemiol Rec 2006;81(34/35):331-40
   PubMedGoogle Scholar
• Konishi E, Shoda M, Kondo T. Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination. Vaccine 2004;22(9-10):1097-103
   PubMed Web of Science ®Google Scholar
• Konishi E, Shoda M, Kondo T. Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist. Vaccine 2006;24(4):516-24
   PubMed Web of Science ®Google Scholar
• Aihara S, Rao CM, Yu YX, et al. Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 1991;5(2):95-109
   PubMed Web of Science ®Google Scholar
• Ni H, Burns NJ, Chang GJ, et al. Comparison of nucleotide and deduced amino acid sequence of the 5′ non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J Gen Virol 1994;75(Pt 6):1505-10
   PubMed Web of Science ®Google Scholar
• Ni H, Chang GJ, Xie H, Trent DW, Barrett AD. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol 1995;76(Pt 2):409-13
   PubMed Web of Science ®Google Scholar
• Arroyo J, Guirakhoo F, Fenner S, et al. Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 2001;75(2):934-42
   PubMed Web of Science ®Google Scholar
• Lee E, Lobigs M. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 2002;76(10):4901-11
   PubMed Web of Science ®Google Scholar
• Chambers T, Droll D, Jiang X, Wold W, Nickells J. JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. Virology 2007;366(1):51-61
   PubMed Web of Science ®Google Scholar
• Xin YY, Ming ZG, Peng GY, Jian A, Min LH. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 1988;39(2):214-17
   PubMed Web of Science ®Google Scholar
• Tandan JB, Ohrr H, Sohn YM, et al. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 2007;25(27):5041-5
   PubMed Web of Science ®Google Scholar
• Hennessy S, Liu Z, Tsai TF, et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 1996;347(9015):1583-6
   PubMed Web of Science ®Google Scholar
• WHO. Global Advisory Committee on Vaccine Safety, 29 – 30 November 2006. Wkly Epidemiol Rec 2007;82(3):18-24
   PubMedGoogle Scholar
• Bista MB, Banerjee MK, Shin SH, et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 2001;358(9284):791-5
   PubMed Web of Science ®Google Scholar
• Ohrr H, Tandan JB, Sohn YM, et al. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 2005;366(9494):1375-8
   PubMed Web of Science ®Google Scholar
• Bista MB, Shrestha JM. Epidemiological situation of Japanese encephalitis in Nepal. J Nepal Med Assoc 2005;44(158):51-6
   PubMedGoogle Scholar
• Hombach J, Solomon T, Kurane I, Jacobson J, Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2 – 3 September, 2004. Vaccine 2005;23(45):5205-11
   PubMed Web of Science ®Google Scholar
• Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine 2000;18(Suppl 2):26-32
   PubMed Web of Science ®Google Scholar
• Barrett AD, Monath TP, Barban V, Niedrig M, Teuwen DE. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on Medicine and Health in the Tropics, Marseille, France, 12 September, 2005. Vaccine 2007;25(15):2758-65
   PubMed Web of Science ®Google Scholar
• Chambers T, Nestorowicz A, Mason P, Rice C. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 1999;73(4):3095-101
   PubMed Web of Science ®Google Scholar
• Guirakhoo F, Zhang ZX, Chambers TJ, et al. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 1999;257(2):363-72
   PubMed Web of Science ®Google Scholar
• Monath TP, Soike K, Levenbook I, et al. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 1999;17(15-16):1869-82
   PubMed Web of Science ®Google Scholar
• Monath TP, Levenbook I, Soike K, et al. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol 2000;74(4):1742-51
   PubMed Web of Science ®Google Scholar
• Monath TP, Myers GA, Beck RA, et al. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys. Biologicals 2005;33(3):131-44
   PubMed Web of Science ®Google Scholar
• Monath TP, McCarthy K, Bedford P, et al. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 2002;20(7-8):1004-18
   PubMed Web of Science ®Google Scholar
• Dean CH, Alarcon JB, Waterston AM, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccine 2005;1(3):106-11
   PubMed Web of Science ®Google Scholar
• Reid M, MacKenzie D, Baron A, et al. Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE). Am J Trop Med Hyg 2006;75(4):659-63
   PubMed Web of Science ®Google Scholar
• Bhatt TR, CrabtreE MB, Guirakhoo F, Monath TP, Miller BR. Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14–14–2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes. Am J Trop Med Hyg 2000;62(4):480-4
   PubMed Web of Science ®Google Scholar
• Eckels KH, Yu YX, Dubois DR, et al. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 1988;6(6):513-18
   PubMed Web of Science ®Google Scholar
• Srivastava AK, Putnak JR, Lee SH, et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 2001;19(31):4557-65
   PubMed Web of Science ®Google Scholar
• Lyons A, Kanesa-Thasan N, Kuschner RA, et al. A Phase II study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Vaccine 2007;25(17):3445-53
   PubMed Web of Science ®Google Scholar
• Monath TP. Japanese encephalitis vaccines: current vaccines and future prospects. Curr Top Microbiol Immunol 2002;267:105-38
   PubMed Web of Science ®Google Scholar
• Hombach J, Barrett AD, Cardosa MJ, et al. Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26 – 27 April, 2004, Bangkok, Thailand. Vaccine 2005;23(21):2689-95
   PubMedGoogle Scholar
• Sugawara K, Nishiyama K, Ishikawa Y, et al. Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Biologicals 2002;30(4):303-14
   PubMed Web of Science ®Google Scholar
• Abe M, Shiosaki K, Hammar L, et al. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines. Virus Res 2006;121(2):152-60
   PubMed Web of Science ®Google Scholar
• Kuzuhara S, Nakamura H, Hayashida K, et al. Non-clinical and Phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine. Vaccine 2003;21(31):4519-26
   PubMed Web of Science ®Google Scholar
• Appaiahgari MB, Vrati S. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells. Vaccine 2004;22(27-28):3669-75
   PubMed Web of Science ®Google Scholar
• Bharati K, Vrati S. Japanese encephalitis: development of new candidate vaccines. Expert Rev Anti Infect Ther 2006;4(2):313-24
   PubMedGoogle Scholar
• Rauthan M, Kaur R, Appaiahgari MB, Vrati S. Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies. Microbes Infect 2004;6(14):1305-11
   PubMed Web of Science ®Google Scholar
• Yang DK, Kweon CH, Kim BH, et al. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice. J Vet Sci 2005;6(2):125-33
   PubMedGoogle Scholar
• Chia SC, Leung PS, Liao CP, Huang JH, Lee ST. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge. Microb Pathog 2001;31(1):9-19
   PubMed Web of Science ®Google Scholar
• Wu SC, Yu CH, Lin CW, Chu IM. The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity. Vaccine 2003;21(19-20):2516-22
   PubMed Web of Science ®Google Scholar
• Alka, Bharati K, Malik YP, Vrati S. Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice. Med Microbiol Immunol 2007;196(4):227-31
   PubMed Web of Science ®Google Scholar
• Hunt AR, Cropp CB, Chang GJ. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J Virol Methods 2001;97(1-2):133-49
   PubMed Web of Science ®Google Scholar
• Konishi E, Fujii A, Mason PW. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol 2001;75(5):2204-12
   PubMed Web of Science ®Google Scholar
• Mutoh E, Ishikawa T, Takamizawa A, et al. Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone. Vaccine 2004;22(20):2599-608
   PubMed Web of Science ®Google Scholar
• Zhang F, Ma W, Zhang L, Aasa-Chapman M, Zhang H. Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line. Virol J 2007;4:17
   PubMed Web of Science ®Google Scholar
• Chang GJ, Hunt AR, Davis B. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol 2000;74(9):4244-52
   PubMed Web of Science ®Google Scholar
• Konishi E, Yamaoka M, Kurane I, Mason PW. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. Virology 2000;268(1):49-55
   PubMed Web of Science ®Google Scholar
• Ashok MS, Rangarajan PN. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model. Vaccine 2002;20(11-12):1563-70
   PubMed Web of Science ®Google Scholar
• Tanabayashi K, Mukai R, Yamada A, et al. Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys. Vaccine 2003;21(19-20):2338-45
   PubMed Web of Science ®Google Scholar
• Wu CJ, Huang HW, Tao MH. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine. Vaccine 2003;21(25-26):3938-45
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wakita T, Yasui K. Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice. J Virol 2003;77(7):4248-60
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang F, Ma W, et al. A plasmid encoding Japanese encephalitis virus PrM and E proteins elicits protective immunity in suckling mice. Microbiol Immunol 2004;48(8):585-90
   PubMed Web of Science ®Google Scholar
• Wu CJ, Li TL, Huang HW, Tao MH, Chan YL. Development of an effective Japanese encephalitis virus-specific DNA vaccine. Microbes Infect 2006;8(11):2578-86
   PubMed Web of Science ®Google Scholar
• Konishi E, Pincus S, Paoletti E, et al. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 1992;190(1):454-8
   PubMed Web of Science ®Google Scholar
• Konishi E, Pincus S, Paoletti E, Shope RE, Wason PW. Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 1994;12(7):633-8
   PubMed Web of Science ®Google Scholar
• Nam JH, Wyatt LS, Chae SL, et al. Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes. Vaccine 1999;17(3):261-8
   PubMed Web of Science ®Google Scholar
• Appaiahgari MB, Saini M, Rauthan M, Jyoti, Vrati S. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis. Microbes Infect 2006;8(1):92-104
   PubMed Web of Science ®Google Scholar
• Nam JH, Cha SL, Cho HW. Immunogenicity of a recombinant MVA and a DNA vaccine for Japanese encephalitis virus in swine. Microbiol Immunol 2002;46(1):23-8
   PubMed Web of Science ®Google Scholar
• Kanesa-Thasan N, Smucny JJ, Hoke CH, et al. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus – poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine 2000;19(4-5):483-91
   PubMed Web of Science ®Google Scholar